Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 367 entries
Sorted by: Best Match Show Resources per page
Infusion phlebitis: relative incidence associated with cefuroxime administered by intermittent and continuous infusion.

Clinical drug investigation

Owens CA, Ambrose PG, Quintiliani R, Nightingale CH, Nicolau DP.
PMID: 18370511
Clin Drug Investig. 1998;15(6):531-5. doi: 10.2165/00044011-199815060-00010.

No abstract available.

Cite
Owens CA, Ambrose PG, Quintiliani R, et al. Infusion phlebitis: relative incidence associated with cefuroxime administered by intermittent and continuous infusion. Clin Drug Investig. 1998;15(6):531-5doi: 10.2165/00044011-199815060-00010.
Owens, C. A., Ambrose, P. G., Quintiliani, R., Nightingale, C. H., & Nicolau, D. P. (1998). Infusion phlebitis: relative incidence associated with cefuroxime administered by intermittent and continuous infusion. Clinical drug investigation, 15(6), 531-5. https://doi.org/10.2165/00044011-199815060-00010
Owens, C A, et al. "Infusion phlebitis: relative incidence associated with cefuroxime administered by intermittent and continuous infusion." Clinical drug investigation vol. 15,6 (1998): 531-5. doi: https://doi.org/10.2165/00044011-199815060-00010
Owens CA, Ambrose PG, Quintiliani R, Nightingale CH, Nicolau DP. Infusion phlebitis: relative incidence associated with cefuroxime administered by intermittent and continuous infusion. Clin Drug Investig. 1998;15(6):531-5. doi: 10.2165/00044011-199815060-00010. PMID: 18370511.
Copy Download .nbib Format: NLM
Prospective randomized comparison of two different sized percutaneous endoscopically placed gastrostomy tubes.

Clinical nutrition (Edinburgh, Scotland)

Duncan HD, Bray MJ, Kapadia SA, Bowling TE, Cole SJ, Gabe SM, Walters ER, Silk DB.
PMID: 16844064
Clin Nutr. 1996 Dec;15(6):317-20. doi: 10.1016/s0261-5614(96)80007-0.

We performed a prospective randomised study of two different sized percutaneous endoscopic gastrostomy (PEG) tubes to determine if tube size influenced the incidence of PEG-related complications. Patients were given prophylactic cefuroxime, if not already on antibiotics at the time...

Cite
Duncan HD, Bray MJ, Kapadia SA, et al. Prospective randomized comparison of two different sized percutaneous endoscopically placed gastrostomy tubes. Clin Nutr. 1996;15(6):317-20doi: 10.1016/s0261-5614(96)80007-0.
Duncan, H. D., Bray, M. J., Kapadia, S. A., Bowling, T. E., Cole, S. J., Gabe, S. M., Walters, E. R., & Silk, D. B. (1996). Prospective randomized comparison of two different sized percutaneous endoscopically placed gastrostomy tubes. Clinical nutrition (Edinburgh, Scotland), 15(6), 317-20. https://doi.org/10.1016/s0261-5614(96)80007-0
Duncan, H D, et al. "Prospective randomized comparison of two different sized percutaneous endoscopically placed gastrostomy tubes." Clinical nutrition (Edinburgh, Scotland) vol. 15,6 (1996): 317-20. doi: https://doi.org/10.1016/s0261-5614(96)80007-0
Duncan HD, Bray MJ, Kapadia SA, Bowling TE, Cole SJ, Gabe SM, Walters ER, Silk DB. Prospective randomized comparison of two different sized percutaneous endoscopically placed gastrostomy tubes. Clin Nutr. 1996 Dec;15(6):317-20. doi: 10.1016/s0261-5614(96)80007-0. PMID: 16844064.
Copy Download .nbib Format: NLM
First and second derivative spectrophotometric assay of mixtures of cefuroxime and cephalexin.

Journal of pharmaceutical and biomedical analysis

Morelli B.
PMID: 16867433
J Pharm Biomed Anal. 1988;6(2):199-209. doi: 10.1016/0731-7085(88)80046-3.

No abstract available.

Cite
Morelli B. First and second derivative spectrophotometric assay of mixtures of cefuroxime and cephalexin. J Pharm Biomed Anal. 1988;6(2):199-209doi: 10.1016/0731-7085(88)80046-3.
Morelli, B. (1988). First and second derivative spectrophotometric assay of mixtures of cefuroxime and cephalexin. Journal of pharmaceutical and biomedical analysis, 6(2), 199-209. https://doi.org/10.1016/0731-7085(88)80046-3
Morelli, B. "First and second derivative spectrophotometric assay of mixtures of cefuroxime and cephalexin." Journal of pharmaceutical and biomedical analysis vol. 6,2 (1988): 199-209. doi: https://doi.org/10.1016/0731-7085(88)80046-3
Morelli B. First and second derivative spectrophotometric assay of mixtures of cefuroxime and cephalexin. J Pharm Biomed Anal. 1988;6(2):199-209. doi: 10.1016/0731-7085(88)80046-3. PMID: 16867433.
Copy Download .nbib Format: NLM
In vitro activity of cefazoline and cefuroxime in presence of essential and trace elements.

Pakistan journal of pharmaceutical sciences

Sultana N, Arayne MS.
PMID: 16414876
Pak J Pharm Sci. 2002 Jul;15(2):41-50.

Present research focuses to evaluate changes in antimicrobial activity of cefazolin sodium and cefuroxime after interactions with essential and trace elements. The minimum inhibitory concentration (MIC) was observed and subsequently compared with the standard MIC's of the respective drug...

Cite
Sultana N, Arayne MS. In vitro activity of cefazoline and cefuroxime in presence of essential and trace elements. Pak J Pharm Sci. 2002;15(2):41-50
Sultana, N., & Arayne, M. S. (2002). In vitro activity of cefazoline and cefuroxime in presence of essential and trace elements. Pakistan journal of pharmaceutical sciences, 15(2), 41-50.
Sultana, Najma, and Arayne, M Saeed. "In vitro activity of cefazoline and cefuroxime in presence of essential and trace elements." Pakistan journal of pharmaceutical sciences vol. 15,2 (2002): 41-50.
Sultana N, Arayne MS. In vitro activity of cefazoline and cefuroxime in presence of essential and trace elements. Pak J Pharm Sci. 2002 Jul;15(2):41-50. PMID: 16414876.
Copy Download .nbib Format: NLM
Speed of recovery from acute exacerbations of chronic obstructive pulmonary disease after treatment with antimicrobials : results of a two-year study.

Clinical drug investigation

Miravitlles M, Zalacain R, Murio C, Ferrer M, Alvarez-Sala JL, Masa JF, Verea H, Ros F, Vidal R.
PMID: 17535055
Clin Drug Investig. 2003;23(7):439-50. doi: 10.2165/00044011-200323070-00003.

OBJECTIVE: We performed a multicentre study under a 2-year observational protocol that included data on time to recovery from acute exacerbations of chronic obstructive pulmonary disease (AE-COPD) in patients receiving moxifloxacin and comparator antimicrobials.PATIENTS AND METHODS: Outpatients with moderate...

Cite
Miravitlles M, Zalacain R, Murio C, et al. Speed of recovery from acute exacerbations of chronic obstructive pulmonary disease after treatment with antimicrobials : results of a two-year study. Clin Drug Investig. 2003;23(7):439-50doi: 10.2165/00044011-200323070-00003.
Miravitlles, M., Zalacain, R., Murio, C., Ferrer, M., Alvarez-Sala, J. L., Masa, J. F., Verea, H., Ros, F., Vidal, R. (2003). Speed of recovery from acute exacerbations of chronic obstructive pulmonary disease after treatment with antimicrobials : results of a two-year study. Clinical drug investigation, 23(7), 439-50. https://doi.org/10.2165/00044011-200323070-00003
Miravitlles, Marc, et al. "Speed of recovery from acute exacerbations of chronic obstructive pulmonary disease after treatment with antimicrobials : results of a two-year study." Clinical drug investigation vol. 23,7 (2003): 439-50. doi: https://doi.org/10.2165/00044011-200323070-00003
Miravitlles M, Zalacain R, Murio C, Ferrer M, Alvarez-Sala JL, Masa JF, Verea H, Ros F, Vidal R. Speed of recovery from acute exacerbations of chronic obstructive pulmonary disease after treatment with antimicrobials : results of a two-year study. Clin Drug Investig. 2003;23(7):439-50. doi: 10.2165/00044011-200323070-00003. PMID: 17535055.
Copy Download .nbib Format: NLM
Trends in the susceptibility to antimicrobial drugs of common pathogens in childhood septicaemia in Nigeria: experience at the University of Maiduguri Teaching Hospital, Nigeria, 1991-1994.

International journal of antimicrobial agents

Akpede GO, Adeyemi O, Ambe JP.
PMID: 18611691
Int J Antimicrob Agents. 1995 Dec;6(2):91-7. doi: 10.1016/0924-8579(95)00023-9.

From 1991 to 1994, Staphylococcus aureus, untyped Coliform spp. and Salmonella spp., other Enterobacteriaceae and other bacteria were isolated from 40.7%, 37.6%, 19.5% and 2.2%, respectively, of 225 confirmed cases of septicaemia in postneonatal infants and children. Overall, 98.9%,...

Cite
Akpede GO, Adeyemi O, Ambe JP. Trends in the susceptibility to antimicrobial drugs of common pathogens in childhood septicaemia in Nigeria: experience at the University of Maiduguri Teaching Hospital, Nigeria, 1991-1994. Int J Antimicrob Agents. 1995;6(2):91-7doi: 10.1016/0924-8579(95)00023-9.
Akpede, G. O., Adeyemi, O., & Ambe, J. P. (1995). Trends in the susceptibility to antimicrobial drugs of common pathogens in childhood septicaemia in Nigeria: experience at the University of Maiduguri Teaching Hospital, Nigeria, 1991-1994. International journal of antimicrobial agents, 6(2), 91-7. https://doi.org/10.1016/0924-8579(95)00023-9
Akpede, G O, et al. "Trends in the susceptibility to antimicrobial drugs of common pathogens in childhood septicaemia in Nigeria: experience at the University of Maiduguri Teaching Hospital, Nigeria, 1991-1994." International journal of antimicrobial agents vol. 6,2 (1995): 91-7. doi: https://doi.org/10.1016/0924-8579(95)00023-9
Akpede GO, Adeyemi O, Ambe JP. Trends in the susceptibility to antimicrobial drugs of common pathogens in childhood septicaemia in Nigeria: experience at the University of Maiduguri Teaching Hospital, Nigeria, 1991-1994. Int J Antimicrob Agents. 1995 Dec;6(2):91-7. doi: 10.1016/0924-8579(95)00023-9. PMID: 18611691.
Copy Download .nbib Format: NLM
Mechanisms of resistance to piperacillin of Enterobacter cloacae strains differ by antibiotic prescription policy.

International journal of antimicrobial agents

Namavar F, Verboom T, van de Klundert JA, van Gestel MH, Zaal J, Maclarena DM.
PMID: 18611803
Int J Antimicrob Agents. 1997;8(3):205-8. doi: 10.1016/s0924-8579(97)00377-4.

During a study of piperacillin resistance among aerobic Gram-negative bacteria, 18 resistant strains of Enterobacter cloacae were obtained from a General Hospital in Rotterdam and 13 from a University Hospital in Amsterdam. The patterns of antibiotic susceptibilities were different:...

Cite
Namavar F, Verboom T, van de Klundert JA, et al. Mechanisms of resistance to piperacillin of Enterobacter cloacae strains differ by antibiotic prescription policy. Int J Antimicrob Agents. 1997;8(3):205-8doi: 10.1016/s0924-8579(97)00377-4.
Namavar, F., Verboom, T., van de Klundert, J. A., van Gestel, M. H., Zaal, J., & Maclarena, D. M. (1997). Mechanisms of resistance to piperacillin of Enterobacter cloacae strains differ by antibiotic prescription policy. International journal of antimicrobial agents, 8(3), 205-8. https://doi.org/10.1016/s0924-8579(97)00377-4
Namavar, F, et al. "Mechanisms of resistance to piperacillin of Enterobacter cloacae strains differ by antibiotic prescription policy." International journal of antimicrobial agents vol. 8,3 (1997): 205-8. doi: https://doi.org/10.1016/s0924-8579(97)00377-4
Namavar F, Verboom T, van de Klundert JA, van Gestel MH, Zaal J, Maclarena DM. Mechanisms of resistance to piperacillin of Enterobacter cloacae strains differ by antibiotic prescription policy. Int J Antimicrob Agents. 1997;8(3):205-8. doi: 10.1016/s0924-8579(97)00377-4. PMID: 18611803.
Copy Download .nbib Format: NLM
In vitro activities of two drug combinations of ceftazidime, cefotaxime, cefuroxime, ciprofloxacin, chloramphenicol, imipenem and temocillin against clinical isolates of Pseudomonas cepacia from patients with cystic fibrosis.

International journal of antimicrobial agents

Kerr JR.
PMID: 18611561
Int J Antimicrob Agents. 1993;3(3):205-9. doi: 10.1016/0924-8579(93)90013-u.

This study utilised the killing curve method to determine the in vitro effects of all possible two drug combinations of ceftazidine, cefotaxime, cefuroxime, ciprofloxacin, chloramphenicol, imipenem and temocillin against 10 strains of Pseudomonas cepacia isolated from the sputa of...

Cite
Kerr JR. In vitro activities of two drug combinations of ceftazidime, cefotaxime, cefuroxime, ciprofloxacin, chloramphenicol, imipenem and temocillin against clinical isolates of Pseudomonas cepacia from patients with cystic fibrosis. Int J Antimicrob Agents. 1993;3(3):205-9doi: 10.1016/0924-8579(93)90013-u.
Kerr, J. R. (1993). In vitro activities of two drug combinations of ceftazidime, cefotaxime, cefuroxime, ciprofloxacin, chloramphenicol, imipenem and temocillin against clinical isolates of Pseudomonas cepacia from patients with cystic fibrosis. International journal of antimicrobial agents, 3(3), 205-9. https://doi.org/10.1016/0924-8579(93)90013-u
Kerr, J R. "In vitro activities of two drug combinations of ceftazidime, cefotaxime, cefuroxime, ciprofloxacin, chloramphenicol, imipenem and temocillin against clinical isolates of Pseudomonas cepacia from patients with cystic fibrosis." International journal of antimicrobial agents vol. 3,3 (1993): 205-9. doi: https://doi.org/10.1016/0924-8579(93)90013-u
Kerr JR. In vitro activities of two drug combinations of ceftazidime, cefotaxime, cefuroxime, ciprofloxacin, chloramphenicol, imipenem and temocillin against clinical isolates of Pseudomonas cepacia from patients with cystic fibrosis. Int J Antimicrob Agents. 1993;3(3):205-9. doi: 10.1016/0924-8579(93)90013-u. PMID: 18611561.
Copy Download .nbib Format: NLM
Cefuroxime axetil.

International journal of antimicrobial agents

Dellamonica P.
PMID: 18611587
Int J Antimicrob Agents. 1994 Mar;4(1):23-36. doi: 10.1016/0924-8579(94)90061-2.

Cefuroxime is the first commercially-available second-generation cephalosporine to be widely used in therapy; it is a semi-synthetic cephalosporin obtained from the 7-cephalosporanic acid nucleus of cephalosporin C. Cefuroxime axetil is the acetoxyethyl ester of cefuroxime. The majority of micro-organisms...

Cite
Dellamonica P. Cefuroxime axetil. Int J Antimicrob Agents. 1994;4(1):23-36doi: 10.1016/0924-8579(94)90061-2.
Dellamonica, P. (1994). Cefuroxime axetil. International journal of antimicrobial agents, 4(1), 23-36. https://doi.org/10.1016/0924-8579(94)90061-2
Dellamonica, P. "Cefuroxime axetil." International journal of antimicrobial agents vol. 4,1 (1994): 23-36. doi: https://doi.org/10.1016/0924-8579(94)90061-2
Dellamonica P. Cefuroxime axetil. Int J Antimicrob Agents. 1994 Mar;4(1):23-36. doi: 10.1016/0924-8579(94)90061-2. PMID: 18611587.
Copy Download .nbib Format: NLM
Antimicrobial resistance patterns and prevalence of class 1 and 2 integrons in Shigella flexneri and Shigella sonnei isolated in Uzbekistan.

Gut pathogens

Madiyarov RS, Bektemirov AM, Ibadova GA, Abdukhalilova GK, Khodiev AV, Bodhidatta L, Sethabutr O, Mason CJ.
PMID: 21143880
Gut Pathog. 2010 Dec 09;2(1):18. doi: 10.1186/1757-4749-2-18.

BACKGROUND: Shigella is a frequent cause of bacterial dysentery in the developing world. Treatment with effective antibiotics is recommended for shigellosis, but options become limited due to globally emerging resistance. One of the mechanisms for the development of resistance...

Cite
Madiyarov RS, Bektemirov AM, Ibadova GA, et al. Antimicrobial resistance patterns and prevalence of class 1 and 2 integrons in Shigella flexneri and Shigella sonnei isolated in Uzbekistan. Gut Pathog. 2010;2(1):18doi: 10.1186/1757-4749-2-18.
Madiyarov, R. S., Bektemirov, A. M., Ibadova, G. A., Abdukhalilova, G. K., Khodiev, A. V., Bodhidatta, L., Sethabutr, O., & Mason, C. J. (2010). Antimicrobial resistance patterns and prevalence of class 1 and 2 integrons in Shigella flexneri and Shigella sonnei isolated in Uzbekistan. Gut pathogens, 2(1), 18. https://doi.org/10.1186/1757-4749-2-18
Madiyarov, Ruslan S, et al. "Antimicrobial resistance patterns and prevalence of class 1 and 2 integrons in Shigella flexneri and Shigella sonnei isolated in Uzbekistan." Gut pathogens vol. 2,1 (2010): 18. doi: https://doi.org/10.1186/1757-4749-2-18
Madiyarov RS, Bektemirov AM, Ibadova GA, Abdukhalilova GK, Khodiev AV, Bodhidatta L, Sethabutr O, Mason CJ. Antimicrobial resistance patterns and prevalence of class 1 and 2 integrons in Shigella flexneri and Shigella sonnei isolated in Uzbekistan. Gut Pathog. 2010 Dec 09;2(1):18. doi: 10.1186/1757-4749-2-18. PMID: 21143880; PMCID: PMC3017001.
Copy Download .nbib Format: NLM
A Case of Giant Hepatic Hydatid Cyst Infected with Morganella morganii and the Literature Review.

Case reports in gastrointestinal medicine

Hakyemez IN, Sit M, Aktas G, Tas T, Mengeloglu FZ, Kucukbayrak A.
PMID: 23198187
Case Rep Gastrointest Med. 2012;2012:591561. doi: 10.1155/2012/591561. Epub 2012 Nov 11.

Hydatid cyst disease is a common worldwide zoonosis. Most of the cysts are located in the liver. Abscess formation due to infection of the cyst is an important complication. M. morganii, a Gram-negative Bacillus, is a quite rare cause...

Cite
Hakyemez IN, Sit M, Aktas G, et al. A Case of Giant Hepatic Hydatid Cyst Infected with Morganella morganii and the Literature Review. Case Rep Gastrointest Med. 2012;2012:591561doi: 10.1155/2012/591561.
Hakyemez, I. N., Sit, M., Aktas, G., Tas, T., Mengeloglu, F. Z., & Kucukbayrak, A. (2012). A Case of Giant Hepatic Hydatid Cyst Infected with Morganella morganii and the Literature Review. Case reports in gastrointestinal medicine, 2012591561. https://doi.org/10.1155/2012/591561
Hakyemez, Ismail Necati, et al. "A Case of Giant Hepatic Hydatid Cyst Infected with Morganella morganii and the Literature Review." Case reports in gastrointestinal medicine vol. 2012 (2012): 591561. doi: https://doi.org/10.1155/2012/591561
Hakyemez IN, Sit M, Aktas G, Tas T, Mengeloglu FZ, Kucukbayrak A. A Case of Giant Hepatic Hydatid Cyst Infected with Morganella morganii and the Literature Review. Case Rep Gastrointest Med. 2012;2012:591561. doi: 10.1155/2012/591561. Epub 2012 Nov 11. PMID: 23198187; PMCID: PMC3502769.
Copy Download .nbib Format: NLM
Randomized controlled trial on the safety of intracameral cephalosporins in cataract surgery.

Clinical ophthalmology (Auckland, N.Z.)

Lam PT, Young AL, Cheng LL, Tam PM, Lee VY.
PMID: 21191447
Clin Ophthalmol. 2010 Dec 08;4:1499-504. doi: 10.2147/OPTH.S15602.

OBJECTIVE: To compare the safety profiles of intracameral cephalosporins in cataract surgery.PATIENTS AND METHODS: In this controlled trial, 129 patients were randomized to one of four groups to receive 1 mg of one of three cephalosporins - cefazolin, cefuroxime,...

Cite
Lam PT, Young AL, Cheng LL, et al. Randomized controlled trial on the safety of intracameral cephalosporins in cataract surgery. Clin Ophthalmol. 2010;4:1499-504doi: 10.2147/OPTH.S15602.
Lam, P. T., Young, A. L., Cheng, L. L., Tam, P. M., & Lee, V. Y. (2010). Randomized controlled trial on the safety of intracameral cephalosporins in cataract surgery. Clinical ophthalmology (Auckland, N.Z.), 41499-504. https://doi.org/10.2147/OPTH.S15602
Lam, Philip T H, et al. "Randomized controlled trial on the safety of intracameral cephalosporins in cataract surgery." Clinical ophthalmology (Auckland, N.Z.) vol. 4 (2010): 1499-504. doi: https://doi.org/10.2147/OPTH.S15602
Lam PT, Young AL, Cheng LL, Tam PM, Lee VY. Randomized controlled trial on the safety of intracameral cephalosporins in cataract surgery. Clin Ophthalmol. 2010 Dec 08;4:1499-504. doi: 10.2147/OPTH.S15602. PMID: 21191447; PMCID: PMC3009998.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 367 entries